-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Diagnosis and Management of Mastocytosis: An Emerging Challenge in Applied Hematology

Program: Education Program
Session: Cytosis: Too Much of a Good Thing
Saturday, December 5, 2015, 2:00 PM-3:30 PM
W224, Level 2 (Orange County Convention Center)
Sunday, December 6, 2015, 7:30 AM-9:00 AM
Valencia A (W415A), Level 4 (Orange County Convention Center)

Peter Valent, MD

Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria

Disclosures: Valent: Novartis: Consultancy , Honoraria . Off Label Use: Treatment of advanced systemic mastocytosis: Cladribine (2CdA) PKC412 (Midostaurin) Interferon-alpha .

See more of: Cytosis: Too Much of a Good Thing
See more of: Education Program
<< Previous Presentation | Next Presentation >>